A detailed history of Degroof Petercam Asset Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Degroof Petercam Asset Management holds 220,300 shares of GILD stock, worth $20.4 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
220,300
Previous 281,800 21.82%
Holding current value
$20.4 Million
Previous $22.8 Billion 29.31%
% of portfolio
0.19%
Previous 0.3%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$71.58 - $87.29 $4.4 Million - $5.37 Million
-61,500 Reduced 21.82%
220,300 $16.1 Billion
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $20.6 Million - $23.4 Million
281,800 New
281,800 $22.8 Billion

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Degroof Petercam Asset Management Portfolio

Follow Degroof Petercam Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Degroof Petercam Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Degroof Petercam Asset Management with notifications on news.